As androgen activation of stably expressed AR has been shown to inhibit proliferation of PC-3 prostate cancer cells [39,41], we investigated the extent to which AR regulates cell cycle progression and cyclin D-CDK4/6 complexes in PC3-Lenti-AR. The gene discussed is CDK4; the disease is prostate carcinoma.